Skip to main content
. Author manuscript; available in PMC: 2019 Jun 1.
Published in final edited form as: Endocrine. 2018 Apr 12;60(3):479–489. doi: 10.1007/s12020-018-1589-1

Fig. 4.

Fig. 4

Proportion achieving target decreases in HbA1c and fasting TGs in the FAS at month 12/LOCF. FAS, full analysis set; HbA1c, glycated hemoglobin; LOCF, last observation carried forward; TGs, triglycerides